Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity.
Diagnostics (Basel). 2023 May 2;13(9):1611. doi: 10.3390/diagnostics13091611.
Diagnostics (Basel). 2023.
PMID: 37175001
Free PMC article.
Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors.
Chernov V, Rybina A, Zelchan R, Medvedeva A, Bragina O, Lushnikova N, Doroshenko A, Usynin E, Tashireva L, Vtorushin S, Abouzayed A, Rinne SS, Sörensen J, Tolmachev V, Orlova A.
Chernov V, et al.
Cancers (Basel). 2023 Mar 7;15(6):1631. doi: 10.3390/cancers15061631.
Cancers (Basel). 2023.
PMID: 36980517
Free PMC article.
Item in Clipboard
Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT.
Liu Y, Yu S, Xu T, Bodenko V, Orlova A, Oroujeni M, Rinne SS, Tolmachev V, Vorobyeva A, Gräslund T.
Liu Y, et al.
Pharmaceutics. 2022 Jul 15;14(7):1475. doi: 10.3390/pharmaceutics14071475.
Pharmaceutics. 2022.
PMID: 35890370
Free PMC article.
Item in Clipboard
Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules.
Rinne SS, Yin W, Borras AM, Abouzayed A, Leitao CD, Vorobyeva A, Löfblom J, Ståhl S, Orlova A, Gräslund T.
Rinne SS, et al.
Biomedicines. 2022 May 31;10(6):1293. doi: 10.3390/biomedicines10061293.
Biomedicines. 2022.
PMID: 35740315
Free PMC article.
Item in Clipboard
Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands.
Lundmark F, Olanders G, Rinne SS, Abouzayed A, Orlova A, Rosenström U.
Lundmark F, et al.
Pharmaceutics. 2022 May 20;14(5):1098. doi: 10.3390/pharmaceutics14051098.
Pharmaceutics. 2022.
PMID: 35631684
Free PMC article.
Item in Clipboard
The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy.
Yin W, Xu T, Altai M, Oroujeni M, Zhang J, Vorobyeva A, Vorontsova O, Vtorushin SV, Tolmachev V, Gräslund T, Orlova A.
Yin W, et al.
Pharmaceutics. 2021 Nov 21;13(11):1974. doi: 10.3390/pharmaceutics13111974.
Pharmaceutics. 2021.
PMID: 34834389
Free PMC article.
Item in Clipboard
Cite
Cite